Pilot Study With Peginterferon, Ribavirin, and Boceprevir Prior to Transplantation to Clear Virus in Hepatitis C Genotype 1 Infected Individuals Undergoing Orthotopic Liver Transplantation

EARLY_PHASE1CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

July 31, 2014

Study Completion Date

July 31, 2014

Conditions
Liver Transplantation
Interventions
DRUG

boceprevir

Trial Locations (1)

46202

Indiana University School of Medicine - IUHealth-University Hospital, Indianapolis

All Listed Sponsors
collaborator

Merck Sharp & Dohme LLC

INDUSTRY

lead

Indiana University

OTHER

NCT01909401 - Pilot Study With Peginterferon, Ribavirin, and Boceprevir Prior to Transplantation to Clear Virus in Hepatitis C Genotype 1 Infected Individuals Undergoing Orthotopic Liver Transplantation | Biotech Hunter | Biotech Hunter